I've flown all over the world in all kinds of jetliners, and usually when the plane gets going, I tune out the safety presentation.
Been there, done that.
But on a recent Southwest Airlines (NYSE: LUV) flight from Money Map Press headquarters in Baltimore to Oakland International Airport, I listened carefully as the flight attendant described the plane's safety features.
And when I looked around, I noticed a lot more passengers than usual doing the exact same thing.
Just two days before, a woman died on a Dallas-bound Southwest flight after an engine failed and she was nearly sucked out of the cabin.
At a time like this, many investors might shy away from The Boeing Co. (NYSE: BA), which made the ill-fated 737 aircraft in question.
But today, I'm going to show you why that would be a big mistake…
A Rare Tragedy
Let me be clear. I'm not making light of what happened. This was a horrible incident, and Jennifer Riordan's family and community are still in mourning.
However, it bears noting that flying in the U.S. remains incredibly safe. Riordan was the first passenger to die on a major U.S. airliner since 2009, and the first ever in the 47 years that Southwest has been flying.
Now then, the reason I paid so much attention to the safety briefing has to do with a message I got from my wife before boarding. She linked me to a photo taken by a passenger that shows folks on that ill-fated flight putting their safety masks on incorrectly.
So, I put my smartphone and tablet down to make sure I knew exactly what to do, should there be an emergency.
I have to say that, overall, the media provided a pretty fair account of Southwest's, as well as Boeing's, "blame" for the incident.
Top Three California Pot Stocks to Watch for the Biggest Gains – Learn How to Cash In Here
However, for Boeing, the world's leading commercial aviation firm and longtime Southwest supplier, the accident served as part of a one-two punch. Shares had come under pressure earlier that week because of a possible trade war with China, where Boeing is also a major supplier.
But five days after the fatal flight, the Chicago-based titan reported record earnings that reflect a boom in commercial aviation and the growth in defense spending.
To show you why Boeing remains such a great stock for the long haul, let's focus on the two main areas that will fuel the company's growth for years to come.
I'll start with the massive upside it faces in passenger flights…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.